Global CLL Posttest

CME

Optimal Therapeutic Sequencing in Relapsed/Refractory CLL: A Global Perspective

Physicians: maximum of 1.50 AMA PRA Category 1 Credits™

European Learners: 1.00 EBAC® CE Credit

Released: October 30, 2024

Expiration: December 29, 2024

Activity

Progress
1
Course Completed

Optimal Therapeutic Sequencing in Relapsed/Refractory CLL: A Global Perspective

Please take this required posttest and earn a 70% or better to claim credit for attending this live event.